Make Home Page | Bookmark this page      
    
HOME
ABOUT US
SERVICES
BACK OFFICE
RESEARCH
ONLINE TRADING
Market
  
Market Analysis Company Information Corporate Actions Other Market
        Gainers & Losers         Advances & Declines         New Highs & Lows         Out / Under Performers
        Index Movers         Historical Returns         Sector Watch         Only Buyers and Sellers
        Value & Volume Toppers         Live Indices         Bulk Deals         Block Deals
        52 Week Highs & Lows         Exchange Holidays         Unusual Volume         Index Constituents
        Detailed Quotes         Company Snapshot         Board of Directors         Profit & Loss
        Quarterly Result         Balance Sheet         Key Financial Ratios         Monthly High Low
        Name Change         Company News         MF Holdings         Director's Report
        Peer Comparison         Company Background         Score Board         Share Holding Pattern
        Technical Chart         Interactive Chart
        BSE Announcements         NSE Announcements         Board Meetings         Book Closure
        Bonus Issues         Rights Issues         De-Listed Shares         Market Turnover
        Change Of Name         Split Of Face Value
        ADR Prices         Forex         FII Investment         MF Investment
        World Indices
Quarterly Results
Cipla Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500087
ISIN Demat
INE059A01026
Book Value
320.5640364
NSE Symbol
CIPLA
Div & Yield %
0.60
Market Cap (Rs. Cr.)
115033.60
P/E
34.98
EPS
40.73
Face Value
2
Last 4 quarterly results of the company with key fields. Click on right side Dropdown box to view more quarters.
Home >> Equity >> Company Information >> Quarterly Results
Quarters
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales3798.313736.463857.73
Other Operating Income583.02497.98460.46
Other Income 265.36319.24157.98
Total Income4646.694553.684476.17
Total Expenditure 3025.473009.063113.50
PBIDT1621.221544.621362.67
Interest 9.066.610.31
PBDT1612.161538.011362.36
Depreciation135.02179.81135.95
Tax348.69329.81340.34
Fringe Benefit Tax0.000.000.00
Deferred Tax14.31-1.30-8.95
Reported Profit After Tax1114.141029.69895.02
Extra-ordinary Items 96.38114.150.00
Adjusted Profit After Extra-ordinary item1017.76915.54895.02
    
EPS (Unit Curr.)14.9914.1711.09
EPS (Adj) (Unit Curr.)14.9914.1711.09
Calculated EPS (Unit Curr.)13.8012.7511.09
Calculated EPS (Adj) (Unit Curr.)13.8012.7511.09
Calculated EPS (Ann.) (Unit Curr.)55.2051.0244.35
Calculated EPS (Adj) (Ann.) (Unit Curr.)55.2051.0244.35
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity161.47161.47161.45
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares000
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares000
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)42.6841.3435.32
PBDTM(%)42.4441.1635.32
PATM(%)29.3327.5623.20